Publication | Open Access
Rituximab versus Azathioprine for Maintenance in ANCA-Associated Vasculitis
1.1K
Citations
23
References
2014
Year
More patients with ANCA-associated vasculitides had sustained remission at month 28 with rituximab than with azathioprine. (Funded by the French Ministry of Health; MAINRITSAN ClinicalTrials.gov number, NCT00748644; EudraCT number, 2008-002846-51.).
| Year | Citations | |
|---|---|---|
Page 1
Page 1